Effects of the Nottingham Augmented Reality (AR) App for Arthritis Hand Joint Pain
Effects of the Nottingham Arthritis App for Arthritis Pain
1 other identifier
interventional
36
1 country
1
Brief Summary
The aim of this run-in design, feasibility study is to assess outcomes (including opioid-use, pain intensity, emotional function, and general physical function) for an augmented reality illusion therapy in participants with chronic hand joint pain due to arthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2022
CompletedFirst Submitted
Initial submission to the registry
November 21, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2023
CompletedJuly 25, 2023
February 1, 2023
1 year
November 21, 2022
July 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Pain, Enjoyment of Life and General Activity scale (PEG)
PEG is a three-Item scale assessing pain intensity and interference. Scale is from 0 (no pain) to 10 (pain as bad as you can imagine).
Change from baseline to day 30
Milligrams of Morphine Equivalent (MME)
MME is a standard measure of opioid use
Change from baseline to day 30
Secondary Outcomes (4)
Resting State brain imaging data
Change from baseline to day 30
Non-opioid pain medicine usage
Change from baseline to day 30
Pain Disability Index (PDI)
Change from baseline to day 30
Patient Health Questionnaire (PHQ-9)
Change from baseline to day 30
Study Arms (1)
Standard of Care followed by AR digital treatment
EXPERIMENTALStandard of care period without active intervention followed by Digital treatment with active intervention
Interventions
Standard of care as prescribed by healthcare provider.
AR software treatment delivered by smartphone app and developed by VRx Medical (VRx) using established principles of illusion therapies (e.g. mirror therapy) for pain management.
Eligibility Criteria
You may qualify if:
- Male and female adults ages 21-80
- Clinical diagnosis of chronic hand pain from arthritis or as determined by study physician 3) Hand joint pain at a severity of 4 and above (on a 0 to 10 scale) daily
- \) Use of prescribed opioids 5) English-speaking, literate, with stable residence 5) Able to operate a smartphone as evidenced by direct observation.
You may not qualify if:
- Major medical illness that might confound effects of pain on function (e.g., advanced cardiac or pulmonary disease)
- Current active alcohol or substance use disorder as evidenced from medical record
- Currently active unstable psychiatric status in previous three months as measured by direct observation, patient self-report, or medical record
- Moderate or severe cognitive impairment as demonstrated by medical diagnosis or clinical observation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VRx Medical Inclead
- National Institute on Drug Abuse (NIDA)collaborator
- San Diego Veterans Healthcare Systemcollaborator
Study Sites (1)
VA San Diego Healthcare System
San Diego, California, 92161, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Rutledge, PhD
San Diego Veterans Healthcare System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2022
First Posted
December 2, 2022
Study Start
June 13, 2022
Primary Completion
June 16, 2023
Study Completion
July 21, 2023
Last Updated
July 25, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share